Cargando…
Long-term effect of the perindopril/indapamide/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects
BACKGROUND: Most antihypertensive drugs used in monotherapy or in combination therapy reduce the left ventricular mass index (LVMI). However, little is known about the effects on LVMI of a triple fixed-dose combination (TFC) therapy, containing in a single pill an angiotensin-converting enzyme inhib...
Autores principales: | Mazza, Alberto, Townsend, Danyelle M., Schiavon, Laura, Torin, Gioia, Lenti, Salvatore, Rossetti, Ciro, Rigatelli, Gianluca, Rubello, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104809/ https://www.ncbi.nlm.nih.gov/pubmed/31627089 http://dx.doi.org/10.1016/j.biopha.2019.109539 |
Ejemplares similares
-
Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial
por: Nedogoda, Sergey V., et al.
Publicado: (2017) -
Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use
por: Syed, Yahiya Y.
Publicado: (2022) -
Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy
por: Borghi, Claudio, et al.
Publicado: (2023) -
Correction to: Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use
por: Syed, Yahiya Y.
Publicado: (2022) -
The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings
por: Mazza, Alberto, et al.
Publicado: (2020)